AbbVie ROA - Return on Assets 2010-2024 | ABBV

AbbVie return on assets for the quarter ending December 31, 2024 was 2.98.

  • AbbVie average return on assets for 2023 was 5, a 42.66% decline from 2022.
  • AbbVie average return on assets for 2022 was 8.72, a 68.34% decline from 2021.
  • AbbVie average return on assets for 2021 was 5.18, a 26.21% increase from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.

AbbVie ROA - Return on Assets 2010-2024 | ABBV

  • AbbVie average return on assets for 2023 was 5, a 42.66% decline from 2022.
  • AbbVie average return on assets for 2022 was 8.72, a 68.34% decline from 2021.
  • AbbVie average return on assets for 2021 was 5.18, a 26.21% increase from 2020.

Roa - return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B